Cargando…
Four different treatment strategies in aggressive fibromatosis: A systematic review
BACKGROUND: The treatment approach for aggressive fibromatosis is changing. Although surgery is the mainstay in common practice, recent literature is reporting a more conservative approach. We compared the local control rate for surgery, surgery with radiotherapy, radiotherapy alone and a wait and s...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067057/ https://www.ncbi.nlm.nih.gov/pubmed/30069502 http://dx.doi.org/10.1016/j.ctro.2018.03.001 |
_version_ | 1783343084373803008 |
---|---|
author | Seinen, Jojanneke M. Niebling, Maarten G. Bastiaannet, Esther Pras, Betty Hoekstra, Harald J. |
author_facet | Seinen, Jojanneke M. Niebling, Maarten G. Bastiaannet, Esther Pras, Betty Hoekstra, Harald J. |
author_sort | Seinen, Jojanneke M. |
collection | PubMed |
description | BACKGROUND: The treatment approach for aggressive fibromatosis is changing. Although surgery is the mainstay in common practice, recent literature is reporting a more conservative approach. We compared the local control rate for surgery, surgery with radiotherapy, radiotherapy alone and a wait and see policy in a systematic review. METHODS: A comprehensive search of the databases PubMed/Medline, Embase and Cochrane, of the medical literature published in 1999 till March 2017 was performed by two reviewers, including articles about extra abdominal aggressive fibromatosis without the genetical variants. A total of 671 studies were assessed for eligibility, and 37 studies were included for analysis, representing 2780 patients. RESULTS: The local control rates for surgery alone, surgery and radiotherapy, radiotherapy alone and observation were 75%, 78%, 85% and 78%, respectively. For patients with recurrent disease observation had a better local control rate than surgery alone (p = 0.001). In the observation group, stabilization of the tumor was seen in median 14 (range 12–35) months. The time to local recurrence in the treatment group was median 17 (range, 11–52) months. CONCLUSION: A watchful conservative first line approach with just observation and closely monitoring, by means of physical examination and MRI, appears to be justified in a subgroup of patients without clinical symptoms and no possible health hazards if the tumor would progress. |
format | Online Article Text |
id | pubmed-6067057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-60670572018-08-01 Four different treatment strategies in aggressive fibromatosis: A systematic review Seinen, Jojanneke M. Niebling, Maarten G. Bastiaannet, Esther Pras, Betty Hoekstra, Harald J. Clin Transl Radiat Oncol Article BACKGROUND: The treatment approach for aggressive fibromatosis is changing. Although surgery is the mainstay in common practice, recent literature is reporting a more conservative approach. We compared the local control rate for surgery, surgery with radiotherapy, radiotherapy alone and a wait and see policy in a systematic review. METHODS: A comprehensive search of the databases PubMed/Medline, Embase and Cochrane, of the medical literature published in 1999 till March 2017 was performed by two reviewers, including articles about extra abdominal aggressive fibromatosis without the genetical variants. A total of 671 studies were assessed for eligibility, and 37 studies were included for analysis, representing 2780 patients. RESULTS: The local control rates for surgery alone, surgery and radiotherapy, radiotherapy alone and observation were 75%, 78%, 85% and 78%, respectively. For patients with recurrent disease observation had a better local control rate than surgery alone (p = 0.001). In the observation group, stabilization of the tumor was seen in median 14 (range 12–35) months. The time to local recurrence in the treatment group was median 17 (range, 11–52) months. CONCLUSION: A watchful conservative first line approach with just observation and closely monitoring, by means of physical examination and MRI, appears to be justified in a subgroup of patients without clinical symptoms and no possible health hazards if the tumor would progress. Elsevier 2018-03-06 /pmc/articles/PMC6067057/ /pubmed/30069502 http://dx.doi.org/10.1016/j.ctro.2018.03.001 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Seinen, Jojanneke M. Niebling, Maarten G. Bastiaannet, Esther Pras, Betty Hoekstra, Harald J. Four different treatment strategies in aggressive fibromatosis: A systematic review |
title | Four different treatment strategies in aggressive fibromatosis: A systematic review |
title_full | Four different treatment strategies in aggressive fibromatosis: A systematic review |
title_fullStr | Four different treatment strategies in aggressive fibromatosis: A systematic review |
title_full_unstemmed | Four different treatment strategies in aggressive fibromatosis: A systematic review |
title_short | Four different treatment strategies in aggressive fibromatosis: A systematic review |
title_sort | four different treatment strategies in aggressive fibromatosis: a systematic review |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067057/ https://www.ncbi.nlm.nih.gov/pubmed/30069502 http://dx.doi.org/10.1016/j.ctro.2018.03.001 |
work_keys_str_mv | AT seinenjojannekem fourdifferenttreatmentstrategiesinaggressivefibromatosisasystematicreview AT nieblingmaarteng fourdifferenttreatmentstrategiesinaggressivefibromatosisasystematicreview AT bastiaannetesther fourdifferenttreatmentstrategiesinaggressivefibromatosisasystematicreview AT prasbetty fourdifferenttreatmentstrategiesinaggressivefibromatosisasystematicreview AT hoekstraharaldj fourdifferenttreatmentstrategiesinaggressivefibromatosisasystematicreview |